Role of EZH2-mediated H3K27me3 in placental ADAM12-S expression: implications for fetoplacental growth

Ya-nan Zhu,Xiao-wen Gan,Fan Pan,Xiao-tian Ni,Leslie Myatt,Wang-sheng Wang and Kang Sun
DOI: https://doi.org/10.1186/s12916-022-02391-4
IF: 9.3
2022-05-27
BMC Medicine
Abstract:Enhancer of zeste homolog 2 (EZH2)-mediated histone 3 lysine 27 trimethylation (H3K27me3) is a transcription silencing mark, which is indispensable for cell lineage specification at the early blastocyst stage. This epigenetic repression is maintained in placental cytotrophoblasts but is lifted when cytotrophoblasts differentiate into syncytiotrophoblasts. However, the physiological impact of this lift remains elusive. Here, we investigated whether lifting EZH2-mediated H3K27me3 during syncytialization upregulates the expression of a short secretory isoform of a disintegrin and metalloprotease 12 (ADAM12-S), a well-recognized placenta-derived protease that cleaves insulin-like growth factor binding protein 3 to increase insulin-like growth factor (IGF) bioavailability for the stimulation of fetoplacental growth. The transcription factor and the upstream signal involved were also explored.
medicine, general & internal
What problem does this paper attempt to address?